BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11352285)

  • 41. [Diabetes mellitus].
    Kawano M; Kanazawa Y
    Nihon Rinsho; 2000 Feb; 58(2):421-5. PubMed ID: 10707569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination oral agent and insulin therapy for type 2 diabetes mellitus.
    Passaro MD; Ratner RE
    Curr Diab Rep; 2001 Oct; 1(2):106-11. PubMed ID: 12643105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approaches.
    Bell DS
    Treat Endocrinol; 2004; 3(2):67-76. PubMed ID: 15743102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of thiazolidinediones and sulfonylureas in patients with diabetes.
    Derosa G; Maffioli P
    Diabetes Technol Ther; 2010 Jun; 12(6):491-501. PubMed ID: 20470234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Constructing an algorithm for managing type 2 diabetes. Focus on role of the thiazolidinediones.
    Wyne KL; Drexler AJ; Miller JL; Bell DS; Braunstein S; Nuckolls JG
    Postgrad Med; 2003 May; Spec No():63-72. PubMed ID: 12785133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral antihyperglycemic therapy for type 2 diabetes: clinical applications.
    Holmboe ES
    JAMA; 2002 Jan; 287(3):373-6. PubMed ID: 11790217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rationale for and role of thiazolidinediones in type 2 diabetes mellitus.
    Lebovitz HE
    Am J Cardiol; 2002 Sep; 90(5A):34G-41G. PubMed ID: 12231077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.
    Arvind A; Memel ZN; Philpotts LL; Zheng H; Corey KE; Simon TG
    Metabolism; 2021 Jul; 120():154780. PubMed ID: 33891949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
    Fisman EZ; Motro M; Tenenbaum A
    Adv Cardiol; 2008; 45():154-170. PubMed ID: 18230961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pioglitazone and sulfonylureas: effectively treating type 2 diabetes.
    Hanefeld M
    Int J Clin Pract Suppl; 2007 Jun; 61(153):20-7. PubMed ID: 17594390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes and diabetes medications.
    Turkoski BB
    Orthop Nurs; 2006; 25(3):227-31. PubMed ID: 16735857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complications of diabetes therapy.
    Corathers SD; Peavie S; Salehi M
    Endocrinol Metab Clin North Am; 2013 Dec; 42(4):947-70. PubMed ID: 24286957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Update on new oral treatment for diabetes].
    Awad J; Schindel B; Schindel Y
    Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897
    [No Abstract]   [Full Text] [Related]  

  • 54. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
    Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
    [No Abstract]   [Full Text] [Related]  

  • 55. Emergency management of oral hypoglycemic drug toxicity.
    Rowden AK; Fasano CJ
    Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Achieving glycemic control in type 2 diabetes: a practical guide for clinicians on oral hypoglycemics.
    Willett LL; Albright ES
    South Med J; 2004 Nov; 97(11):1088-92. PubMed ID: 15586599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic management of diabetes mellitus.
    Mozersky RP
    J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Knack of treatment with oral hypoglycemic drugs in the elderly].
    Komatsu M; Hashizume K
    Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxicology of oral antidiabetic medications.
    Spiller HA; Sawyer TS
    Am J Health Syst Pharm; 2006 May; 63(10):929-38. PubMed ID: 16675650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of antidiabetes agents in pregnancy: current practice and controversy.
    Slocum JM; Sosa ME
    J Perinat Neonatal Nurs; 2002 Sep; 16(2):40-53; quiz 2 p following 84. PubMed ID: 12233944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.